Cetuximab for the Treatment of Colorectal Cancer

20071,801 citationsJournal Articlebronze Open Access

Authors

Derek J. Jonker · University of Ottawa

Chris J. O’Callaghan · Queen's University

Christos S. Karapetis · Flinders Medical Centre

John Zalcberg · University of Melbourne

Dongsheng Tu · Queen's University

Heather-Jane Au

Scott Berry · Sunnybrook Health Science Centre

Abstract

Cetuximab improves overall survival and progression-free survival and preserves quality-of-life measures in patients with colorectal cancer in whom other treatments have failed. (ClinicalTrials.gov number, NCT00079066 [ClinicalTrials.gov].).

Topics & Keywords

Colorectal Cancer Treatments and Studies Colorectal Cancer Surgical Treatments Advanced Breast Cancer Therapies

Publication Details

Published in: New England Journal of Medicine

Volume 357, Issue 20, pp. 2040-2048

DOI: 10.1056/nejmoa071834

Field-Weighted Citation Impact: 58.38

Command Palette

Cetuximab for the Treatment of Colorectal Cancer

Authors

Abstract

Topics & Keywords

Publication Details